NO20014234D0 - Pyrazol-3-one derivatives as factor Xa inhibitors - Google Patents

Pyrazol-3-one derivatives as factor Xa inhibitors

Info

Publication number
NO20014234D0
NO20014234D0 NO20014234A NO20014234A NO20014234D0 NO 20014234 D0 NO20014234 D0 NO 20014234D0 NO 20014234 A NO20014234 A NO 20014234A NO 20014234 A NO20014234 A NO 20014234A NO 20014234 D0 NO20014234 D0 NO 20014234D0
Authority
NO
Norway
Prior art keywords
pyrazol
inhibitors
derivatives
factor
Prior art date
Application number
NO20014234A
Other languages
Norwegian (no)
Other versions
NO20014234L (en
Inventor
Dieter Dorsch
Horst Juraszyk
Werner Mederski
Christos Tsaklakidis
Hanns Wurziger
Sabine Bernotat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20014234D0 publication Critical patent/NO20014234D0/en
Publication of NO20014234L publication Critical patent/NO20014234L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20014234A 1999-03-03 2001-08-31 Pyrazol-3-one derivatives as factor Xa inhibitors NO20014234L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19909237A DE19909237A1 (en) 1999-03-03 1999-03-03 Pyrazol-3-one derivatives
PCT/EP2000/001695 WO2000051989A1 (en) 1999-03-03 2000-02-29 Pyrazole-3-on-derivative as factor xa inhibitors

Publications (2)

Publication Number Publication Date
NO20014234D0 true NO20014234D0 (en) 2001-08-31
NO20014234L NO20014234L (en) 2001-10-24

Family

ID=7899522

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014234A NO20014234L (en) 1999-03-03 2001-08-31 Pyrazol-3-one derivatives as factor Xa inhibitors

Country Status (17)

Country Link
EP (1) EP1157010A1 (en)
JP (1) JP2002538143A (en)
KR (1) KR20010102428A (en)
CN (1) CN1342148A (en)
AU (1) AU2916500A (en)
BR (1) BR0008608A (en)
CA (1) CA2364908A1 (en)
CZ (1) CZ20013164A3 (en)
DE (1) DE19909237A1 (en)
HU (1) HUP0200242A3 (en)
MX (1) MXPA01008844A (en)
NO (1) NO20014234L (en)
PL (1) PL350941A1 (en)
RU (1) RU2001126566A (en)
SK (1) SK12152001A3 (en)
WO (1) WO2000051989A1 (en)
ZA (1) ZA200108064B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455525B1 (en) 1999-11-04 2002-09-24 Cephalon, Inc. Heterocyclic substituted pyrazolones
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
WO2005012255A1 (en) * 2003-08-01 2005-02-10 Mitsubishi Pharma Corporation Remedy for inflammatory joint diseases
DE102008020113A1 (en) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituted dihydropyrazolones and their use
DE102005019712A1 (en) 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone and its use
DE102006050513A1 (en) 2006-10-26 2008-04-30 Bayer Healthcare Ag New substituted dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia
DE102006050516A1 (en) 2006-10-26 2008-04-30 Bayer Healthcare Ag New pyrazol-3-one compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful e.g. to treat and/or prophylaxis heart-circulation diseases, heart failure, anemia, chronic kidney diseases and renal failure
DE102006050515A1 (en) 2006-10-26 2008-04-30 Bayer Healthcare Ag New substituted dipyridiyl-dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia
DE102007044032A1 (en) 2007-09-14 2009-03-19 Bayer Healthcare Ag New substituted heteroaryl compounds are hypoxia-inducible factor prolyl-4-hydroxylase inhibitors useful to treat and/or prevent e.g. circulatory heart diseases, heart failure, anemia, chronic kidney diseases and renal failure
DE102007048447A1 (en) 2007-10-10 2009-04-16 Bayer Healthcare Ag New substituted dihydropyrazole-3-thione compounds are hypoxia inducible factor-prolyl-4-hydroxylase inhibitor, useful for preparing medicament to treat and/or prevent e.g. cardiovascular diseases, wound healing and anemia
DE102010044131A1 (en) 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituted sodium 1H-pyrazole-5-olate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
JP3994453B2 (en) * 1995-10-13 2007-10-17 日産化学工業株式会社 Pyrazolones

Also Published As

Publication number Publication date
ZA200108064B (en) 2003-01-02
WO2000051989A1 (en) 2000-09-08
RU2001126566A (en) 2004-02-27
CZ20013164A3 (en) 2001-12-12
AU2916500A (en) 2000-09-21
MXPA01008844A (en) 2002-05-14
HUP0200242A3 (en) 2002-12-28
CA2364908A1 (en) 2000-09-08
BR0008608A (en) 2002-01-02
KR20010102428A (en) 2001-11-15
JP2002538143A (en) 2002-11-12
HUP0200242A2 (en) 2002-11-28
PL350941A1 (en) 2003-02-24
DE19909237A1 (en) 2000-09-07
EP1157010A1 (en) 2001-11-28
NO20014234L (en) 2001-10-24
SK12152001A3 (en) 2002-03-05
CN1342148A (en) 2002-03-27

Similar Documents

Publication Publication Date Title
NO20021239D0 (en) Pteridinones as kinase inhibitors
NO20022139L (en) Quinazoline derivatives as VEGF inhibitors
EE200300049A (en) Imidazole derivatives
NO20023828L (en) Pyrimidin-4-one derivatives as LDL-PLA2 inhibitors
DE60009747D1 (en) ADMANTAN DERIVATIVES
ATE360620T1 (en) IMIDAZOLE DERIVATIVES
NO20015065D0 (en) Pyrazolobenzodiazepines as CDK2 inhibitors
DE50010060D1 (en) THIAZOLYLAMID DERIVATIVES
DK1187814T3 (en) 5-phenyl-pyrimidine derivatives
PT1237857E (en) NEW FENALQUILOXY-PHENYL DERIVATIVES
ATE257148T1 (en) PROPARGYLETHER DERIVATIVES
NO20035440D0 (en) Pyrrolidine derivatives as factor XA inhibitors
NO20016201D0 (en) Tienopyrimidines as phosphodiesterase inhibitors
ATE374747T1 (en) MONOFLUORALKYL DERIVATIVES
DK1154988T3 (en) Mevinoline derivatives
NO20021251D0 (en) Tienoisoxazolyl- and thienylpyrrazolyl-phenoxy-substituted propyl derivatives useful as D4 antagonists
NO20021959D0 (en) Tetrahydrotiopyranephthalazinone derivatives as PDE4 inhibitors
NO20014234D0 (en) Pyrazol-3-one derivatives as factor Xa inhibitors
DE60006703D1 (en) 4-HYDROXYBIPHENYLHYDRAZID DERIVATIVES
DK1187815T3 (en) 4-phenyl-pyrimidine derivatives
ATE293592T1 (en) RESOCINE DERIVATIVES
NO20023001D0 (en) Substituted piperazine derivatives as MTP inhibitors
DK1222193T3 (en) Imidazole derivatives as phosphodiesterase VII inhibitors
DK1189886T3 (en) Ethanesulfonyl-piperidine derivatives
DK1178984T3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application